|
Outcomes
|
Community-acquired ARDS
|
Hospital-acquired ARDS
|
ICU-acquired ARDS
|
p
|
|---|
| |
(n = 70)
|
(n = 83)
|
(n = 143)
| |
|
Mortality –no.(% [95 % CI])
|
|
In ICU
|
26 (37*[26–49])
|
51 (61[51–72])
|
75 (52[44–61])
|
0.001
|
|
At 28-day
|
31 (44*[33–56])
|
56 (68[57–78])
|
89 (62[54–70])
|
0.012
|
|
At 60-day
|
33 (47*[35–59])
|
58 (70[60–80])
|
92 (64[56–72])
|
0.001
|
|
At 90-day
|
33 (47*[35–59])
|
59 (71[61–81])
|
97 (68[60–76])
|
0.001
|
|
In hospital
|
34 (49*[37–60])
|
61 (74[64–83])
|
97 (68[60–76])
|
0.001
|
|
No. of ventilator-free days, days 1 to 28
|
16 ± 9
|
14 ± 10
|
11 ± 9†
|
0.001
|
|
No. of ICU-free days, Days 1 to 28
|
8 ± 10*
|
4 ± 8
|
3 ± 6
|
0.001
|
-
Abbreviations: ARDS acute respiratory distress syndrome, MV mechanical ventilation, LOS length of stay, ICU intensive care unit
- All values are expressed as No of patients (% [95 % CI]) or mean ± SD
-
*
p < 0.05: Community-acquired ARDS vs. hospital-acquired ARDS and vs ICU-acquired ARDS
-
†
p < 0.05: ICU-acquired ARDS vs. Community-acquired ARDS and vs Hospital-acquired ARDS
